Dr. Martens’ main shareholder sells down its stake

IngreLux, a Luxembourg company owned by funds advised by the investment firm Permira, has sold 65 million ordinary shares in Dr. Martens at a price of 395 pence (€4.73-$5.35) each in a placing, raising gross proceeds of approximately £257 million (€307.7m-$347.8m). The price represents a 6 percent discount from the ...

Keep reading this article by becoming a member


Subscribe today for just €7,60 a week

Your membership benefits:

  • Our executive edition of Shoe Intelligence (Regular PDF format or E-Format) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Unlimited access to shoeintelligence.com - all insight, analysis and statistics 24h/day available online
  • Powerful search and access to over 16,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Breaking news

If you aren’t ready to subscribe now, choose the 30 day trial for 1€. Already a Shoe Intelligence subscriber? Sign in here.